期刊文献+

巯基嘌呤甲基转移酶在嘌呤类药物代谢中的作用及其多态性的研究进展

下载PDF
导出
摘要 对巯基嘌呤甲基转移酶在巯嘌呤类药物体内代谢过程中的作用、其活性水平与药物活性物质在体内的浓度与药效、药物的毒副作用的关系、酶活性多态性种族差异及基因遗传多态性关系进行综述。为指导临床合理用药,避免药物不良反应及个体化用药提供参考。
作者 杨凡 许景峰
出处 《医药导报》 CAS 2009年第4期493-495,共3页 Herald of Medicine
  • 相关文献

参考文献30

  • 1KRYNETSKI E Y, TAI H L, YATES C R, et al. Genetic polymorphism of thiopurine S-methyhransferase : clinical importance and molecular mechanisms [J]. Pharmacogertetics, 1996, 6(4) : 279 - 290. 被引量:1
  • 2COLOMBEL J F, FERRARI N, DEBUYSERE H, et al. Genotypic analysis of thiopurine S-methyhransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J]. Gastroenterology, 2000, 118(6) : 1025 - 1030. 被引量:1
  • 3GUNNARSDOTYIR S , ELFARRA A A. Distinct tissue distribution of metabolites of the novel glutathione activated thiopurine prodrugs cis-6-( 2-aeetylvinylthio ) purine and trans-6-( 2-acetylvinylthio ) guanine and 6-thioguanine in the mouse [ J ]. Drug Metab Disposition, 2003, 31(6): 718-726. 被引量:1
  • 4BAKER D E, PHARM D, FASCP, FASHP. Pharmacogenomics of azathioprine and 6-mercaptopurine in gastroenterologic therapy [ J ]. Rev Gastroenterol Disord, 2003, 3(3): 150- 157. 被引量:1
  • 5AHMED M, MD SANDHYA S, et al. Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease [ J ]. Inflamm Bowel Dis, 2007, 13 (2) : 380 - 385. 被引量:1
  • 6詹钟平,杨岫岩,黄民,王一西,连帆,梁柳琴,叶玉津,许韩师.硫唑嘌呤致血液系统危象的临床特征与酶学基础[J].中华风湿病学杂志,2005,9(3):145-148. 被引量:16
  • 7魏红,李成荣,李智毅,刘芳,黄民,王国兵,吴珏珩,张建萍.硫嘌呤甲基转移酶遗传多态性检测在6-MP个体化治疗中的意义[J].中国医院药学杂志,2007,27(1):5-7. 被引量:7
  • 8LENNARD L, LILLEYMAN J S, VAN LOON J, et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia [ J ]. Lancet, 1990, 336 ( 8709 ) : 225- 229. 被引量:1
  • 9LENNARD L, GIBSON B E, NICOLE T, et al. Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia [ J ]. Arch Dis Childhood, 1993, 69 (5) :577 - 579. 被引量:1
  • 10詹钟平,杨岫岩,梁柳琴,王一西,黄民,连帆.风湿病患者硫唑嘌呤代谢酶活性分布及其临床意义[J].中华内科杂志,2006,45(7):537-539. 被引量:5

二级参考文献59

  • 1詹钟平,杨岫岩,黄民,王一西,连帆,梁柳琴,叶玉津,许韩师.硫唑嘌呤致血液系统危象的临床特征与酶学基础[J].中华风湿病学杂志,2005,9(3):145-148. 被引量:16
  • 2张建萍 黄民 关永源 等.广东瑶族和汉族儿童TPMT遗传多态性研究[J].中国临床药理学杂志,2002,18:418-421. 被引量:1
  • 3Zhang JP, Huang M, Guan YY, et al. Molecular mechanisms of genetic polymorphim of thiopurine S-methyltransferase. Chin J Clin Pharmacol, 2002, 18 , 453-457. 被引量:1
  • 4Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basts for azathiopurine and mercaptopurine intolerance. Ann Intern Med, 1997, 126: 608-614. 被引量:1
  • 5Tai HL, Fessing MY, Bonten EJ, et al. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase(TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT * 2, TPMT * 3A, TPMT * 3B or TPMT * 3C. Pharmacogenetics, 1999, 9: 641-650. 被引量:1
  • 6Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics, 1999,9: 37-42. 被引量:1
  • 7Weinshilboum R. Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Dispos, 2001, 29: 601-605. 被引量:1
  • 8Spire-Vayron de la Moureyre C, Debuysere H, Sabbagh N, et al.Detection of known and new mutations in the thiopurine S-methyltransferase gene by single-strand conformation polymorphism analysis. Hum Murat, 1998, 12, 177-185. 被引量:1
  • 9Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathiopurine therapy.Gastroenterology, 2000, 118: 1025-1030. 被引量:1
  • 10Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics : gene sequence polymorphisms. Clin Pharmacol Ther, 1997, 62: 60-73. 被引量:1

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部